Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients

被引：152

作者：

Syrjäkoski, K

Vahteristo, P

Eerola, H

Tamminen, A

Kivinummi, K

Sarantaus, L

Holli, K

Blomqvist, C

Kallioniemi, OP

Kainu, T

Nevanlinna, H

机构：

[1] Univ Tampere, Inst Med Technol, Canc Genet Lab, FIN-33101 Tampere, Finland

[2] Tampere Univ Hosp, Dept Oncol, Tampere, Finland

[3] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00029 Helsinki, Finland

[4] Univ Helsinki, Cent Hosp, Dept Oncol, FIN-00029 Helsinki, Finland

[5] Univ Uppsala Hosp, Dept Oncol, S-75185 Uppsala, Sweden

[6] Univ Tampere, Inst Med Technol, Canc Genet Lab, FIN-33101 Tampere, Finland

[7] NHGRI, Canc Genet Branch, Bethesda, MD 20892 USA

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2000年 / 92卷 / 18期

关键词：

D O I：

10.1093/jnci/92.18.1529

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1529 / 1531

页数：3

共 22 条

[1]

*AM SOC CLIN ONC, 1996, J CLIN ONCOL, V14, P1737

[2] BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer [J].

Couch, FJ ;

DeShano, ML ;

Blackwood, MA ;

Calzone, K ;

Stopfer, J ;

Campeau, L ;

Ganguly, A ;

Rebbeck, T ;

Weber, BL ;

Jablon, L ;

Cobleigh, MA ;

Hoskins, K ;

Garber, JE .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (20) :1409-1415

[3] Recommendations for medical management of hereditary breast and ovarian cancer: The French National Ad Hoc Committee [J].

Eisinger, F ;

Alby, N ;

Bremond, A ;

Dauplat, J ;

Espie, M ;

Janiaud, P ;

Kuttenn, F ;

Lebrun, JP ;

Lefranc, JP ;

Pierret, J ;

Sobol, H ;

Stoppa-Lyonnet, D ;

Thouvenin, D ;

Tristant, H ;

Feingold, J .

ANNALS OF ONCOLOGY, 1998, 9 (09) :939-950

[4]

*FINN CANC RES, 1997, CANC SOC FINL PUBL, V58

[5] Germ-line BRCA1 mutations in women with sporadic breast cancer:: Clinical correlations [J].

Garcia-Patiño, E ;

Gomendio, B ;

Provencio, M ;

Silva, JM ;

Garcia, JM ;

España, P ;

Bonilla, F .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) :115-120

[6] Evidence of founder mutations in Finnish BRCA1 and BRCA2 families [J].

Huusko, P ;

Pääkkönen, K ;

Launonen, V ;

Pöyhönen, M ;

Blanco, G ;

Kauppila, A ;

Puistola, U ;

Kiviniemi, H ;

Kujala, M ;

Leisti, J ;

Winqvist, R .

AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (06) :1544-1548

[7]

Johannesdottir G, 1996, CANCER RES, V56, P3663

[8] A STRONG CANDIDATE FOR THE BREAST AND OVARIAN-CANCER SUSCEPTIBILITY GENE BRCA1 [J].

MIKI, Y ;

SWENSEN, J ;

SHATTUCKEIDENS, D ;

FUTREAL, PA ;

HARSHMAN, K ;

TAVTIGIAN, S ;

LIU, QY ;

COCHRAN, C ;

BENNETT, LM ;

DING, W ;

BELL, R ;

ROSENTHAL, J ;

HUSSEY, C ;

TRAN, T ;

MCCLURE, M ;

FRYE, C ;

HATTIER, T ;

PHELPS, R ;

HAUGENSTRANO, A ;

KATCHER, H ;

YAKUMO, K ;

GHOLAMI, Z ;

SHAFFER, D ;

STONE, S ;

BAYER, S ;

WRAY, C ;

BOGDEN, R ;

DAYANANTH, P ;

WARD, J ;

TONIN, P ;

NAROD, S ;

BRISTOW, PK ;

NORRIS, FH ;

HELVERING, L ;

MORRISON, P ;

ROSTECK, P ;

LAI, M ;

BARRETT, JC ;

LEWIS, C ;

NEUHAUSEN, S ;

CANNONALBRIGHT, L ;

GOLDGAR, D ;

WISEMAN, R ;

KAMB, A ;

SKOLNICK, MH .

SCIENCE, 1994, 266 (5182) :66-71

[9] Frequency of breast cancer attributable to BRCA1 in a population-based series of American women [J].

Newman, B ;

Mu, H ;

Butler, LM ;

Millikan, RC ;

Moorman, PG ;

King, MC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (12) :915-921

[10] Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility [J].

Offit, K ;

Biesecker, BB ;

Burt, RW ;

Clayton, EW ;

Garber, JE ;

Kahn, MJE .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) :1730-1736

← 1 2 3 →